Jupiter Life Line Hospitals Limited has informed the Exchange regarding Appointment of M/s V.J Talati & Co as Cost Auditor of the company w.e.f. May 15, 2026.
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jupiter Life Line Hospitals reported consolidated revenue from operations of Rs 14,997.87 million for FY2026, up 15% from Rs 13,024.02 million in the previous year. Consolidated net profit after tax remained relatively flat at Rs 1,941.87 million vs Rs 1,937.54 million. The Board declared an interim dividend of Rs 1 per share (10%) with record date May 22, 2026. A stock split was approved, subdividing each Rs 10 share into 5 shares of Rs 2 each. Dr. Ajay Thakker was appointed as Chairman & Whole Time Director. An exceptional item of Rs 48.87 million was recorded due to increased gratuity liability from new labour codes. The Board also appointed M/s V.J. Talati & Co as Cost Auditor for FY 2026-27. Joint statutory auditors issued an unmodified opinion on both standalone and consolidated financial results.
The 15% revenue growth and flat PAT suggest cost pressures may be compressing margins. The stock split makes shares more affordable for retail investors. The unchanged dividend and clean audit opinion are positives for shareholders.